NEW YORK, July 7 (Reuters) - Barclays Plc (BARC.L) has hired Jim Birchenough from Wells Fargo & Co (WFC.N) as its chairman of global healthcare investment banking, a spokesperson for the British bank confirmed, after Reuters reported on the appointment on Friday.
Birchenough last served as vice chairman of biopharma investment banking at Wells Fargo.
In his new role, Birchenough will also lead Barclays' global biopharma investment banking unit alongside Alexis de Rosnay, who joined the bank last year and is taking on an expanded role in addition to his responsibilities as chairman of global healthcare investment banking.
More than two dozen U.S. investment bankers have left Barclays since January when it named two new global co-heads of investment banking.
They are Cathal Deasy, former co-head of Credit Suisse Group AG investment banking and capital markets, and Taylor Wright, former co-head of Morgan Stanley (MS.N) global capital markets.
Persons:
Jim Birchenough, Birchenough, Wells, Alexis de Rosnay, Darren Campili, Jim, Richard Landgarten, Cathal Deasy, Taylor Wright, Morgan Stanley, David Carnevali, Anirban Sen, Mark Porter, Will Dunham, Richard Chang
Organizations:
YORK, Barclays Plc, Wells Fargo & Co, Reuters, Barclays, BMO Capital Markets, Lehman Brothers, Wells, Credit Suisse Group, Thomson
Locations:
Wells, Wells Fargo, San Francisco, New York